How To Select The Right Biologics CDMO Partner

By Abby Sorensen, Marketing Manager, Scorpius BioManufacturing

When selecting a biologics contract development and manufacturing organization (CDMO) partner, it is crucial to consider both essential and strategic characteristics. Essential attributes include manufacturing capabilities, capacity, quality management systems, scalability, effective communication, and regulatory experience. Strategic characteristics to consider include a fully integrated CDMO, facility considerations such as layout and workflow, risk mitigation through single-use bioprocessing facilities, ease of scale-up, ongoing process excellence, analytical method development and validation capabilities, scale considerations, formulation capabilities, and global regulatory expertise. By carefully evaluating these factors, companies can choose a biologics CDMO partner that aligns with their program's needs and goals.

Gain valuable insights into the factors to consider when selecting a CDMO, such as experience, regulatory compliance, capacity, track record, and cultural fit.